Fjarde Ap-fonden’s CVS Health CVS Stock Holding History

Fjarde Ap-fonden’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35.7M	Buy	345,400 +7,700	+2%	+$687K	0.17%	117
2026 Q1	$24.3M	Buy	337,700 +131,150	+63%	+$10.1M	0.13%	147
2025 Q4	$16.4M	Sell	206,550 -2,600	-1%	-$205K	0.14%	140
2025 Q3	$15.8M	Sell	209,150 -869	-0.4%	-$59.6K	0.14%	153
2025 Q2	$14.5M	Buy	210,019 +37,200	+22%	+$2.44M	0.13%	160
2025 Q1	$11.7M	Sell	172,819 -130,700	-43%	-$7.82M	0.14%	149
2024 Q4	$13.6M	Sell	303,519 -15,900	-5%	-$892K	0.14%	142
2024 Q3	$20.1M	Buy	+319,419	New	+$18.6M	0.2%	100
2024 Q1	$26.5M	Buy	332,419 +12,400	+4%	+$947K	0.29%	66
2023 Q4	$25.3M	Sell	320,019 -15,400	-5%	-$1.1M	0.32%	62
2023 Q3	$23.4M	Buy	335,419 +3,400	+1%	+$241K	0.31%	62
2023 Q2	$23M	Sell	332,019 -41,400	-11%	-$2.95M	0.28%	69
2023 Q1	$27.7M	Buy	373,419 +17,300	+5%	+$1.45M	0.37%	54
2022 Q4	$33.2M	Buy	356,119 +1,532	+0.4%	+$148K	0.47%	41
2022 Q3	$32.9M	Hold	354,587	–	–	0.41%	45
2022 Q2	$32.9M	Buy	354,587 +6,800	+2%	+$664K	0.41%	45
2022 Q1	$35.2M	Buy	347,787 +4,000	+1%	+$420K	0.35%	52
2021 Q4	$35.5M	Sell	343,787 -26,844	-7%	-$2.48M	0.31%	66
2021 Q3	$31.5M	Sell	370,631 -3,600	-1%	-$302K	0.29%	71
2021 Q2	$31.2M	Sell	374,231 -16,400	-4%	-$1.34M	0.29%	72
2021 Q1	$29.4M	Buy	390,631 +3,700	+1%	+$270K	0.27%	76
2020 Q4	$26.4M	Sell	386,931 -19,200	-5%	-$1.25M	0.25%	77
2020 Q3	$23.7M	Buy	406,131 +17,700	+5%	+$1.1M	0.26%	76
2020 Q2	$25.2M	Buy	388,431 +21,700	+6%	+$1.37M	0.32%	60
2020 Q1	$21.8M	Sell	366,731 -9,900	-3%	-$661K	0.35%	58
2019 Q4	$28M	Sell	376,631 -14,600	-4%	-$1.03M	0.34%	57
2019 Q3	$24.7M	Sell	391,231 -25,769	-6%	-$1.53M	0.32%	66
2019 Q2	$22.7M	Sell	417,000 -26,800	-6%	-$1.44M	0.29%	70
2019 Q1	$23.9M	Buy	443,800 +110,303	+33%	+$6.81M	0.3%	65
2018 Q4	$21.9M	Buy	333,497 +60,793	+22%	+$4.54M	0.38%	51
2018 Q3	$21.5M	Sell	272,704 -10,705	-4%	-$765K	0.32%	68
2018 Q2	$18.2M	Sell	283,409 -1,388	-0.5%	-$91.5K	0.28%	71
2018 Q1	$17.7M	Buy	284,797 +566	+0.2%	+$40.6K	0.27%	80
2017 Q4	$20.6M	Buy	284,231 +45,563	+19%	+$3.31M	0.31%	67
2017 Q3	$19.4M	Buy	238,668 +3,427	+1%	+$271K	0.37%	56
2017 Q2	$18.9M	Buy	235,241 +22,836	+11%	+$1.8M	0.38%	53
2017 Q1	$16.7M	Sell	212,405 -15,563	-7%	-$1.24M	0.4%	53
2016 Q4	$18M	Sell	227,968 -21,898	-9%	-$1.77M	0.42%	48
2016 Q3	$22.2M	Buy	249,866 +2,350	+0.9%	+$222K	0.49%	41
2016 Q2	$23.7M	Sell	247,516 -5,095	-2%	-$508K	0.55%	39
2016 Q1	$26.2M	Buy	252,611 +31,379	+14%	+$3.05M	0.61%	35
2015 Q4	$21.6M	Sell	221,232 -2,118	-0.9%	-$207K	0.57%	39
2015 Q3	$21.5M	Sell	223,350 -12,245	-5%	-$1.29M	0.6%	34
2015 Q2	$24.7M	Sell	235,595 -18,668	-7%	-$1.91M	0.6%	33
2015 Q1	$26.2M	Sell	254,263 -21,465	-8%	-$2.17M	0.6%	32
2014 Q4	$26.6M	Sell	275,728 -20,552	-7%	-$1.81M	0.58%	33
2014 Q3	$23.6M	Sell	296,280 -27,477	-8%	-$2.17M	0.5%	37
2014 Q2	$24.4M	Sell	323,757 -20,733	-6%	-$1.57M	0.48%	42
2014 Q1	$25.8M	Buy	344,490 +1,481	+0.4%	+$105K	0.51%	37
2013 Q4	$24.5M	Sell	343,009 -17,242	-5%	-$1.11M	0.51%	39
2013 Q3	$20.4M	Sell	360,251 -28,827	-7%	-$1.72M	0.44%	47
2013 Q2	$22.2M	Buy	+389,078	New	+$22.5M	0.46%	44

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fjarde Ap-fonden's CVS Position: Q2 2026 in Review

Fjarde Ap-fonden increased its CVS Health (CVS) stake by 2.3% in Q2 2026, buying an estimated $687K and bringing the position to 345,400 shares worth $35.7M. The position accounts for 0.17% of the portfolio, ranked #117.

Fjarde Ap-fonden first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Fjarde Ap-fonden held 345,400 shares of CVS Health worth $35.7M as of Q2 2026.
Fjarde Ap-fonden bought 7,700 CVS Health shares in Q2 2026, an estimated $687K.
CVS Health made up 0.17% of Fjarde Ap-fonden's portfolio in Q2 2026, its #117 holding.
Fjarde Ap-fonden first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Fjarde Ap-fonden's 13F filing for Q2 2026, filed 29 Jul 2026.